Patent details

Basic Information

Publication number:

EP3938368

PCT Application Number:

US2020021648

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP207170275

PCT Publication Number:

WO2020185648

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF

French Title of Invention:

FORME D'UN COMPOSÉ AVEC UNE BIOAVAILABILITÉ AMELIORÉE ET SES FORMULATIONS

German Title of Invention:

VERBINDUNG FORM MIT VERBESSERTER BIOFÜGBARKEIT UND IHREN FORMULIERUNGEN

SPC Number:

Dates

Filing date:

09/03/2020

Grant date:

07/06/2023

EP Publication Date:

19/01/2022

PCT Publication Date:

17/09/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/06/2023

EP B1 Publication Date:

07/06/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/03/2024

Expiration date:

09/03/2040

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/05/2023

 

 

Name:

PTC Therapeutics, Inc.

Address:

100 Corporate Court,, South Plainfield, NJ 07080, United States (US)

Inventor

1

Name:

UDDIN, Akm, Nasir

Address:

United States (US)

2

Name:

VAZE, Onkar, Shripad

Address:

United States (US)

3

Name:

DALI, Mandar, Vasant

Address:

United States (US)

Priority

Priority Number:

201962816402 P

Priority Date:

11/03/2019

Priority Country:

United States (US)

Classification

IPC classification:

C07D 487/04;

Publication

European Patent Bulletin

Issue number:

202323

Publication date:

07/06/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages